September 29, 2021
1 minute read
Fresenius Medical Care North America has announced the appointment of three individuals to clinical leadership positions.
These included Kathleen belmonte, MS, IA, FNP-BC, MBA, as Chief Nursing Officer and Senior Vice President of Clinical Services for Fresenius Kidney Care; Benjamin Hippen, MD, FASN, FAST, as Senior Vice President and Head of Transplant Medicine for the Global Medical Bureau; and Shelly nash, DO, FACOOG, as Senior Vice President and Director of Medical Information for the FMCNA.
With the appointments, the company seeks to improve patient outcomes, increase transplant access and embrace connected health technologies to support home dialysis, according to a press release.
“We welcome these exceptional clinical leaders who bring many years of in-depth experience both inside and outside our company,” Bill Valle, CEO of FMCNA, said in the statement. “These people will help us continue to be the leader in value-driven care and transformative kidney care models that slow disease progression, while improving dialysis and home transplant rates, quality clinical and information technology to improve experiences and affordability for the benefit of employees. , physician partners, payers and, most importantly, our patients. “
The release provided some details on the roles Belmonte, Hippen and Nash will play in their new positions:
- As part of her role, Belmonte will lead care delivery efforts across the ‘continuum of renal care’, oversee career advancement opportunities, and continue to implement COVID-19 policies and procedures, particularly with respect to concerns vaccination efforts;
- Hippen, who has 15 years of experience as a general nephrologist and transplant specialist and practicing physician, will focus on transplantation as it relates to patient-centered care; and
- Nash, who was previously director of medical information for AdventHealth, will develop strategies to improve communication between clinical services and information technology.
Franklin W. Maddux, MD, FACP, Fresenius Medical Care’s global chief medical officer also commented on the appointments in the statement.
âThis expansion of our leadership team underscores our commitment to improving patient outcomes globally by recognizing the new leadership capabilities needed in the business,â he said. âUnder their leadership in nursing, health information technology and organ transplantation, we will continue to foster innovation, expertise and credibility that will enhance our ability to deliver innovative care and holistic products of the highest quality. “